Sökresultat - Shakeel Modak

Förfina resultatet
  1. 1
    Anti-GD2 immunotherapy for neuroblastoma

    Anti-GD2 immunotherapy for neuroblastoma av Sameer Farouk Sait, Shakeel Modak

    Publicerad 2017
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  2. 2
    Norepinephrine Transporter as a Target for Imaging and Therapy

    Norepinephrine Transporter as a Target for Imaging and Therapy av Neeta Pandit‐Taskar, Shakeel Modak

    Publicerad 2017
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  3. 3
    Management of desmoplastic small round cell tumor

    Management of desmoplastic small round cell tumor av Andrea Hayes‐Jordan, Michael P. LaQuaglia, Shakeel Modak

    Publicerad 2016
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  4. 4
    Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma

    Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma av Brian H. Kushner, Kim Kramer, Shakeel Modak, Nai-KongV. Cheung

    Publicerad 2009
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Successful Multifold Dose Escalation of Anti-G<sub>D2</sub> Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study

    Successful Multifold Dose Escalation of Anti-G<sub>D2</sub> Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study av Brian H. Kushner, Kim Kramer, Shakeel Modak, Nai‐Kong V. Cheung

    Publicerad 2011
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma

    Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma av Brian H. Kushner, Kim Kramer, Shakeel Modak, Nai‐Kong V. Cheung

    Publicerad 2006
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    Ototoxicity from high‐dose use of platinum compounds in patients with neuroblastoma

    Ototoxicity from high‐dose use of platinum compounds in patients with neuroblastoma av Brian H. Kushner, Amy Budnick, Kim Kramer, Shakeel Modak, Nai‐Kong V. Cheung

    Publicerad 2006
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study

    Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study av Shakeel Modak, Brian H. Kushner, Ellen M. Basu, Stephen S. Roberts, Nai‐Kong V. Cheung

    Publicerad 2017
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High-Risk Neuroblastoma in Second or Later Remission

    Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High-Risk Neuroblastoma in Second or Later Remission av Brian H. Kushner, Irene Y. Cheung, Shakeel Modak, Kim Kramer, Govind Ragupathi, Nai‐Kong V. Cheung

    Publicerad 2014
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Humanized 3F8 Anti-G<sub>D2</sub>Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma

    Humanized 3F8 Anti-G<sub>D2</sub>Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma av Brian H. Kushner, Irene Y. Cheung, Shakeel Modak, Ellen M. Basu, Stephen S. Roberts, Nai‐Kong V. Cheung

    Publicerad 2018
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-<i>Cis</i>-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission

    Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-<i>Cis</i>-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblast... av Nai‐Kong V. Cheung, Irene Y. Cheung, Brian H. Kushner, Irina Ostrovnaya, Elizabeth Chamberlain, Kim Kramer, Shakeel Modak

    Publicerad 2012
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    Local Control With 21-Gy Radiation Therapy for High-Risk Neuroblastoma

    Local Control With 21-Gy Radiation Therapy for High-Risk Neuroblastoma av Dana L. Casey, Brian H. Kushner, Nai‐Kong V. Cheung, Shakeel Modak, Michael P. LaQuaglia, Suzanne L. Wolden

    Publicerad 2016
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  13. 13
    Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G<sub>D2</sub>immunotherapy and isotretinoin: a prospective Phase II study

    Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G<sub>D2</sub>immunotherapy and isotretinoin: a prospective Phase II s... av Brian H. Kushner, Irina Ostrovnaya, Irene Y. Cheung, Deborah Kuk, Kim Kramer, Shakeel Modak, Karima Yataghene, Nai‐Kong V. Cheung

    Publicerad 2015
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  14. 14
    Thiotepa-Based High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Recurrent or Progressive CNS Germ Cell Tumors

    Thiotepa-Based High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Recurrent or Progressive CNS Germ Cell Tumors av Shakeel Modak, Sharon L. Gardner, Ira J. Dunkel, Casilda Balmaceda, Marc K. Rosenblum, Douglas C. Miller, Steven Halpern, Jonathan L. Finlay

    Publicerad 2004
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: <scp>L</scp>ong‐term progression‐free survival of patients with resistant neuroblastoma

    A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: <scp>L</scp>ong‐term progression‐free survival of patients with resistant neuroblastoma av Brian H. Kushner, Nai‐Kong V. Cheung, Shakeel Modak, Oren J. Becher, Ellen M. Basu, Stephen S. Roberts, Kim Kramer, Ira J. Dunkel

    Publicerad 2016
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  16. 16
    Key role for myeloid cells: Phase II results of anti‐G<sub>D2</sub> antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblastoma

    Key role for myeloid cells: Phase II results of anti‐G<sub>D2</sub> antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblasto... av Nai‐Kong V. Cheung, Irene Y. Cheung, Kim Kramer, Shakeel Modak, Deborah Kuk, Neeta Pandit‐Taskar, Elizabeth Chamberlain, Irina Ostrovnaya, Brian H. Kushner

    Publicerad 2014
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  17. 17
    Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression

    Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression av Irene Y. Cheung, Nai‐Kong V. Cheung, Shakeel Modak, Audrey Mauguen, Yi Feng, Ellen M. Basu, Stephen S. Roberts, Govind Ragupathi, Brian H. Kushner

    Publicerad 2020
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  18. 18
    Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin

    Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin av Brian H. Kushner, Irina Ostrovnaya, Irene Y. Cheung, Deborah Kuk, Shakeel Modak, Kim Kramer, Stephen S. Roberts, Ellen M. Basu, Karima Yataghene, Nai‐Kong V. Cheung

    Publicerad 2015
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  19. 19
    Treatment and outcome of adult‐onset neuroblastoma

    Treatment and outcome of adult‐onset neuroblastoma av Maya Suzuki, Brian H. Kushner, Kim Kramer, Ellen M. Basu, Stephen S. Roberts, William J. Hammond, Michael P. LaQuaglia, Suzanne L. Wolden, Nai‐Kong V. Cheung, Shakeel Modak

    Publicerad 2018
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  20. 20
    Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

    Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment av Nidale Tarek, Jean-Benoît Le Luduec, Meighan M. Gallagher, Junting Zheng, Jeffrey M. Venstrom, Elizabeth Chamberlain, Shakeel Modak, Glenn Heller, Bo Dupont, Nai‐Kong V. Cheung, Katharine C. Hsu

    Publicerad 2012
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: